Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05926960 |
|---|---|
| Brief Title: | A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced Melanoma (PORTSIDE) |
| First Submitted : | April 3, 2023 |
| First Submitted that Met QC Criteria : | June 23, 2023 |
| First Posted : | July 3, 2023 |
| Last Update Submitted that Met QC Criteria : | April 19, 2024 |
| Last Update Posted : | April 23, 2024 |